Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to * ResearchAndMarkets.com's* offering.
The Global Vaccine Adjuvants Market has witnessed a remarkable surge in growth, attributed to the pressing need for enhanced vaccination efficacy amid rising infectious disease threats. Valued at USD 0.72 billion in 2022, the market anticipates robust expansion projecting a 6.56% CAGR through 2028. This notable growth trajectory signals a surge in demand for vaccine adjuvants critical for developing stronger, longer-lasting immune responses and ensuring global public health security.
In response to the escalating threats posed by emerging diseases such as the H1N1 influenza, Zika virus, and the COVID-19 pandemic, the importance of vaccine adjuvants has risen to the forefront. These additives, which augment the immune response to vaccines, have become pivotal in the rapid development and deployment of vaccines, ensuring broader coverage and protection.
*North America Dominates the Vaccine Adjuvan**ts Landscape as Regulatory Excellence Encourages Market Confidence*
The North American region secures its position as a leading contributor to the Global Vaccine Adjuvants Market, aided by the presence of a robust healthcare infrastructure, major pharmaceutical entities, and stringent evaluation processes. These factors, coupled with active engagement in research and innovation, have bolstered both the production and adoption of adjuvanted vaccines within the region.
*Human Vaccine Adjuvants and Commercial Applications Lead Market Segments*
Within the market, the Human Vaccine Adjuvants segment and Commercial Applications have emerged as dominant forces, driven by a growing global populace and an intensifying public health focus on human vaccination programs. As the world grapples with the importance of immunization, particularly in the wake of the COVID-19 pandemic, the infusion of adjuvants into vaccination efforts has taken center stage in safeguarding communal health.
*All-encompassing Insights and Competitive Landscape Propel Market Understanding*
The comprehensive analysis of the Global Vaccine Adjuvants Market encompasses various product types such as adjuvant emulsions, pathogen components, and particulate adjuvants, among others. With a detailed examination of market dynamics, the report offers critical insights into driving factors, challenges, trends, and offers a competitive landscape that underscores the principal entities at the forefront of market innovation.
*Segmental Highlights:*
· Product Categories: Adjuvant Emulsions, Pathogen Components, Saponin-Based Adjuvants, Particulate Adjuvants, Other Adjuvants
· Market Segments: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
· Applications: Research and Commercial Applications
· Geographical Regions: North America, Europe, Asia-Pacific, South America, Middle East & Africa
The findings reveal an invaluable perspective on the future of the vaccine adjuvants market, serving as a bellwether for stakeholders and industry participants eager to understand the shifting landscape of global vaccine efforts.
*Key Attributes:*
*Report Attribute* *Details*
No. of Pages 189
Forecast Period 2022 - 2028
Estimated Market Value (USD) in 2022 $0.72 Billion
Forecasted Market Value (USD) by 2028 $1.04 Billion
Compound Annual Growth Rate 6.5%
Regions Covered Global
*A selection of companies mentioned in this report includes*
· Dynavax Technologies
· Croda International Plc
· Gsk Plc
· Novavax
· Spi Pharma (A Subsidiary of Associated British Foods Plc)
· Agenus Inc.
· Phibro Animal Health Corporation
· Aurorium (Formerly Vertellus)
· Merck Kgaa
· Vaxine Pty Ltd
For more information about this report visit https://www.researchandmarkets.com/r/krak92
*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
*Attachment*
· Global Vaccine Adjuvants Market
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900